The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program

NACompletedINTERVENTIONAL
Enrollment

751

Participants

Timeline

Start Date

December 30, 2017

Primary Completion Date

March 31, 2024

Study Completion Date

April 15, 2024

Conditions
Pre-diabetes
Interventions
BEHAVIORAL

Lifestyle modification

Participants in the treatment arm will receive structured, locally tailored, group-based lifestyle interventions that consist of a core intervention phase (3 months) and a maintenance phase (33 months). The core intervention phase will consist of twice weekly group sessions on nutrition, exercise and goal-setting within the first 6 weeks followed by 6 weeks of self-directed lifestyle modification. During the maintenance phase, the participants will receive monthly short message service (SMS) on health tips as well as 6 monthly telephone calls from program coordinators.

DRUG

Metformin

Metformin will be will be prescribed to treatment group participants at highest risk of diabetes conversion (i.e.IFG + IGT or IFG + HbA1c ≥6.0%) after at least 6 months of lifestyle interventions at a starting dose of 250 mg twice a day followed by up-titration to 500 mg twice a day after 3 months if the participants do not experience any gastrointestinal side effects.

OTHER

Financial incentives

Participants will be given cash incentives if they meet the weight loss target, which is pre-defined as 5% of baseline weight, at the 3rd, 6th, 12th, 18th, 24th, 30th and 36th month of study period.

Trial Locations (1)

169608

Singapore General Hospital, Singapore

All Listed Sponsors
collaborator

Ministry of Health, Singapore

OTHER_GOV

collaborator

Health Promotion Board, Singapore

OTHER_GOV

collaborator

Singapore Clinical Research Institute

OTHER

collaborator

Duke-NUS Graduate Medical School

OTHER

lead

Singapore General Hospital

OTHER

NCT03503942 - The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program | Biotech Hunter | Biotech Hunter